Clinical Trial Update: Investigator Initiated Study - Asenapine Early Psychosis [Phase 4]

View source ↗

Summary

Investigator-initiated Phase 4 study evaluating asenapine for early psychosis; status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• First Episode Psychosis
• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)

Snippet

Sponsor: Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec | Conditions: Schizophrenia and Disorders With Psychotic Features, Disorders | Phase 4 | Status: UNKNOWN